Clinical Trial Update: Low Molecular Weight Heparin or no Treatment Following Cesarean Delivery [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating low molecular weight heparin versus no treatment after cesarean delivery to prevent thromboembolism has completed and posted results on…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thromboembolism

Drugs mentioned

• Enoxaparin (enoxaparin sodium)

Snippet

Sponsor: University of Utah | Conditions: Thromboembolism | Phase 2 | Status: COMPLETED | Results posted: 2025-09-04